Cargando…
Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.
The new proliferation marker, tissue polypeptide-specific antigen (TPS), representing the specific epitope M3 of tissue polypeptide antigen, and three conventional biochemical markers, CEA, CA 19-9 and CA-195, were analysed in 69 patients with advanced gastrointestinal tumours. The aim of our study...
Autores principales: | Kornek, G., Schenk, T., Raderer, M., Djavarnmad, M., Scheithauer, W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033446/ https://www.ncbi.nlm.nih.gov/pubmed/7529527 |
Ejemplares similares
-
Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
por: Rebhandl, W., et al.
Publicado: (1998) -
Serum tissue polypeptide-specific antigen (TPS): what is its diagnostic value?
por: Valik, D, et al.
Publicado: (2000) -
Response to: Serum tissue polypetide-specific antigen (TPS): what is its diagnostic value – reply
por: Felberbauer, F X, et al.
Publicado: (2000) -
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
por: Pasanen, P. A., et al.
Publicado: (1994) -
The TPS begins to shine
Publicado: (2015)